← Back to Search

Breast Pump Device for Breast Pumping in Healthy Subjects

N/A
Recruiting
Led By Ashley Wofford Leong, MD
Research Sponsored by Momtech Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day (single visit)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new electric breast pump with breastfeeding women to see if it fits well, is comfortable, and easy to use.

Who is the study for?
This trial is for healthy breastfeeding individuals who are not currently pregnant, have no breast or nipple injuries, infections, or piercings, and haven't had breast surgery. Participants must be using an electric breast pump regularly and willing to attend five testing visits over 3-4 months while continuing to breastfeed.
What is being tested?
The study is evaluating the design of a new electric breast pump device by having participants use prototypes of a breast shield and Freedom Double Electric Breast Pump. The focus is on assessing the feasibility of these designs through multiple testing sessions.
What are the potential side effects?
Since this trial is for engineering evaluation purposes rather than health outcomes, specific side effects related to health aren't anticipated. However, discomfort from using different prototype devices may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day (single visit)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day (single visit) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Breast shield comfort
Breast shield ease of use
Breast shield fit
Secondary study objectives
Participant comparison of device to breastfeeding
Participant comparison of device to current commercial breast pump
Volume of milk expressed

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prototypes of Breast Shield and Freedom Double Electric Breast PumpExperimental Treatment1 Intervention
Prototypes of breast shield and Freedom Double Electric Breast Pump

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The electric breast pump operates by creating a vacuum that mimics a baby's suckling, stimulating milk flow from the breast. This mechanism is important for healthy lactating mothers as it enables efficient milk extraction, helps maintain milk supply, relieves engorgement, and allows for milk storage. This is particularly beneficial for mothers who need to be away from their infants or face challenges with direct breastfeeding.
Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children.

Find a Location

Who is running the clinical trial?

Momtech Inc.Lead Sponsor
Ashley Wofford Leong, MDPrincipal InvestigatorIndependent Physician
Sarah Adams, MDPrincipal InvestigatorIndependent Physician
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Prototypes of breast shield and Freedom Double Electric Breast Pump Clinical Trial Eligibility Overview. Trial Name: NCT05222581 — N/A
Healthy Subjects Research Study Groups: Prototypes of Breast Shield and Freedom Double Electric Breast Pump
Healthy Subjects Clinical Trial 2023: Prototypes of breast shield and Freedom Double Electric Breast Pump Highlights & Side Effects. Trial Name: NCT05222581 — N/A
Prototypes of breast shield and Freedom Double Electric Breast Pump 2023 Treatment Timeline for Medical Study. Trial Name: NCT05222581 — N/A
~5 spots leftby Oct 2025